SHH and hematologic disorder: Numerous studies have indicated a close correlation between the aberrant activation of the SHH signaling pathway and the occurrence of various types of tumors such as cancers of skin, brain, liver, gallbladder, pancreas, stomach, colon, breast, lung, prostate, and hematological malignancies.20, 21, 22